Agilent Technologies ClearSeq Comprehensive Cancer research panel
04 March, 2015
Agilent Technologies has launched the ClearSeq Comprehensive Cancer research panel, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
Agilent Technologies ClearSeq Comprehensive Cancer research panel
04 March, 2015 | Supplied by: Agilent Technologies Australia Pty LtdAgilent Technologies has launched the ClearSeq Comprehensive Cancer research panel, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
Agilent Technologies OneSeq target enrichment for next-generation sequencing
03 March, 2015 | Supplied by: Agilent Technologies Australia Pty LtdAgilent Technologies has introduced OneSeq, an all-in-one target enrichment product for next-generation sequencing. The product is designed to detect and analyse copy number variations, loss of heterozygosity and mutations in a single reaction for use in constitutional disease research.
A more sensitive peanut allergy test
02 March, 2015Chemists at the University of Connecticut have developed a peanut allergy test which is said to be far more sensitive than current procedures. It is hoped that the blood test will be better able to diagnose the severity of an individual's allergic reaction.
Celsis Accel microbial screening system
02 March, 2015 | Supplied by: CelsisThe Celsis Accel system allows products to be quickly released from micro hold, reducing manufacturing cycle times and inventory requirements for home, beauty and pharmaceutical product manufacturers.
A more sensitive peanut allergy test
02 March, 2015
Chemists at the University of Connecticut have developed a peanut allergy test which is said to be far more sensitive than current procedures. It is hoped that the blood test will be better able to diagnose the severity of an individual's allergic reaction.
EKF Stanbio Chemistry GSP LiquiColor diabetic biomarker test
20 February, 2015 | Supplied by: EKF DiagnosticsEKF Diagnostics has introduced a diabetic biomarker test that provides a 2- to 3-week indicator of average blood glucose. The Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor test closes the information gap between daily blood glucose testing and the 2- to 3-month HbA1c reading.
Gravity explains why cells are microscopic
20 February, 2015 | Supplied by: American Society for Cell BiologyThe average animal cell is 10 µm across - why? Why aren't they bigger?
EKF Stanbio Chemistry GSP LiquiColor diabetic biomarker test
20 February, 2015 | Supplied by: EKF DiagnosticsEKF Diagnostics has introduced a diabetic biomarker test that provides a 2- to 3-week indicator of average blood glucose. The Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor test closes the information gap between daily blood glucose testing and the 2- to 3-month HbA1c reading.
Tecan Spark 10M multimode microplate reader
18 February, 2015 | Supplied by: Tecan AustraliaThe Spark 10M multimode microplate reader, from Tecan, is designed to offer flexibility and productivity in cell biology and genomics applications. From microbiology research and cell-based assays to rapid DNA quantification, the product delivers a combination of advanced capabilities and ease of use to simplify daily work.
Gravity explains why cells are microscopic
18 February, 2015 | Supplied by: American Society for Cell Biology
The average animal cell is 10 µm across - why? Why aren't they bigger?
Placental stem cells could treat heart failure
13 February, 2015An international research team has found that stem cells collected from the placenta, which is generally discarded after childbirth, show promise as a treatment for heart failure.
Sheffield NHS lab is sure about CytoSure arrays
09 February, 2015 | Supplied by: Oxford Gene TechnologyFollowing a highly stringent National Health Service (NHS) tender for the supply of oligo-based cytogenetics research arrays, Sheffield Children's NHS Foundation Trust has seamlessly transferred to the CytoSure ISCA 8x60k platform from Oxford Gene Technology (OGT).
A microbial portrait of the New York City Subway system
06 February, 2015
Anthrax and Bubonic plague were among the 637 known bacterial, viral, fungal and animal species identified in the New York City Subway system. Only 12% of the bacteria species sampled are known to have some association with disease, but more interestingly still, 48.3% of the DNA sampled did not match any known organism.
New European project to combat antibiotic resistance
05 February, 2015As the problem of antimicrobial resistance grows worldwide, over 30 European academic partners and five pharmaceutical companies have launched a new project under the New Drugs 4 Bad Bugs (ND4BB) program.
